Evidence map›Paper›PMID 29296624›Full record

ReviewAnnals of clinical and translational neurology2017

Efficacy and safety of anti-amyloid-

Jia-Jie Mo, Jin-Yu Li, Zheng Yang, Zhou Liu, Jin-Shan Feng

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Annals of clinical and translational neurology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Aducanumab for the treatment of Alzheimer's disease: a systematic review.Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society · 2023
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Review
  8. Article
  9. Vaccines for Alzheimer's disease: a brief scoping review.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jia-Jie MoDepartment of Functional Neurosurgery Beijing Tiantan Hospital Capital Medical University Beijing 100061 China.ORCID 0000-0002-9721-1378
Jin-Yu LiDepartment of General Surgery the Second Xiangya Hospital Central South University Changsha 410011 China.
Zheng YangDepartment of Psychology Guangdong Medical University Zhanjiang 524023 China.
Zhou LiuDepartment of Neurology Affiliated Hospital of Guangdong Medical University Zhanjiang 524023 China.
Jin-Shan FengScientific Research Center (Campus Zhanjiang) Guangdong Medical University Zhanjiang 524023 China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To review the optimality and safety of different anti-Amyloid-

Identifiers

PMID29296624
PMCPMC5740249

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.